Oslo, October 14, 2016: Serodus ASA (Oslo Axess: SER) Eva Steiness (CEO) has today purchased 84 583 shares at an average price of NOK 1,15 per share. After registration of these shares Dr. Steiness has 2 353 437 shares and 100 000 warrants. The shareholdings of Dr. Eva Steiness is after this be 5.29%.

For more information contact:

Tore Kvam

CFO, Serodus ASA

Mobile: +47 959 34 199

e-mail: tore.kvam@serodus.com

Serodus ASA is a Norwegian drug development company, focusing on new therapeutic products for the treatment of diabetes and diabetic comorbidities with large unmet clinical needs. The company's business model is to seek partnering with international pharmaceutical companies after having demonstrated clinical effect in humans. For more information, see www.serodus.com.

Serodus ASA published this content on 22 October 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 22 October 2016 11:23:01 UTC.

Original documenthttp://www.serodus.com/News/2016/DISCLOSURE-OF-HOLDINGS-AND-MANDATORY-NOTIFICATION-OF-TRADE-PRIMARY-INSIDERS-New-article

Public permalinkhttp://www.publicnow.com/view/5BF3E780C054AD24266D34419F7B7F6FE9FB32EB